Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q2 FY24 results · Jul–Sep 2023
Neuland Laboratories reported revenue from operations of ₹417.75 crore (up 42.2% from Q2 FY23) and net profit of ₹89.25 crore (up 132.1% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 417.75 | 293.71 | +42.2% | 362.99 | +15.1% |
| Other income | 3.05 | 0.24 | 13x | 2.04 | +49.5% |
| Total income | 420.80 | 293.94 | +43.2% | 365.03 | +15.3% |
| Profit before tax | 121.59 | 53.19 | +128.6% | 83.16 | +46.2% |
| Net profit for the period | 89.25 | 38.46 | +132.1% | 61.88 | +44.2% |
| EPS, basic (₹) | 69.56 | 29.97 | +132.1% | 48.23 | +44.2% |
| Net margin (%) | 21.4 | 13.1 | 17.0 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 417.75 | 293.71 | +42.2% | 362.99 | +15.1% |
| Other income | 3.05 | 0.24 | 13x | 2.04 | +49.5% |
| Total income | 420.80 | 293.94 | +43.2% | 365.03 | +15.3% |
| Profit before tax | 121.40 | 53.06 | +128.8% | 83.50 | +45.4% |
| Net profit for the period | 89.06 | 38.33 | +132.3% | 62.22 | +43.1% |
| EPS, basic (₹) | 69.42 | 29.88 | +132.3% | 48.50 | +43.1% |
| Net margin (%) | 21.3 | 13.1 | 17.1 |
Consolidated
- Filed with BSE
- 08 Nov 2023, 15:50 IST
- Board meeting
- 07 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Nov 2023, 15:50 IST
- Board meeting
- 07 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE